Skip to main content
Fig. 3 | Respiratory Research

Fig. 3

From: Once-daily single-inhaler versus twice-daily multiple-inhaler triple therapy in patients with COPD: lung function and health status results from two replicate randomized controlled trials

Fig. 3

Change from baseline in weighted mean FEV1 over 0–24 h at Week 12. BUD, budesonide; CFB, change from baseline; CI, confidence interval; FEV1, forced expiratory volume in 1 s; FF, fluticasone furoate; FOR, formoterol; ITT, intent-to-treat; LS, least squares; mPP, modified per protocol; TIO, tiotropium; UMEC, umeclidinium; VI, vilanterol.

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us